Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 49

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 3
Chunk 49
---
 forfeiture statutes. Many jurisdictions remain fully able to take
action to prevent the proceeds of such product candidates from entering their state. Our investors and prospective investors should be
aware of these potentially relevant laws in considering whether to invest in us.

Failure to comply with health and data protection laws and regulations
could lead to government enforcement actions (which could include civil or criminal penalties), private litigation, and/or adverse publicity
and could negatively affect our operating results and business.

We and any potential collaborators may be subject
to federal, state, and foreign data protection laws and regulations, policies and contractual obligations that apply to the collection,
transmission, storage, processing and use of personal information or personal data, which among other things, impose certain requirements
relating to the privacy, security and transmission of personal information. The legislative and regulatory landscape for privacy and data
protection continues to evolve in jurisdictions worldwide, and there has been an increasing focus on privacy and data protection issues
with the potential to affect our business. Complying with such requirements can be difficult, time-consuming, expensive, and could require
us to change our business practices and put in place additional compliance mechanisms. Failure to comply with laws, regulations and contractual
and other obligations governing personal or other sensitive information could result in enforcement actions against us, including fines,
imprisonment of company officials and public censure, processing penalties, claims for damages by affected individuals, damage to our
reputation and loss of goodwill. It is possible that new and existing laws may be interpreted and applied in a manner that is inconsistent
with our practices and our efforts to comply with the evolving data protection rules may be unsuccessful.

In the United States, numerous federal and state
laws and regulations, including federal health information privacy laws, state data breach notification laws, state health information
privacy laws, and federal and state consumer protection laws (e. g., Section 5 of the Federal Trade Commission Act), that govern the collection,
use, disclosure and protection of health-related and other personal information could apply to our operations or the operations of our
programs and their collaborators. In addition, we may obtain health information from third parties (including research institutions from
which we obtain clinical trial data) that are subject to privacy and security requirements under HIPAA, as amended by the Health Information
Technology for Economic and Clinical Health Act of 2009, or HITECH. HIPAA establishes privacy and security standards that limit the use
and disclosure of individually identifiable health information, or protected health information, and require